Neuronal neprilysin overexpression is associated with attenuation of Aβ-related spatial memory deficit

Neurobiology of Disease

Volumn 24, Issue 3, 2006, Pages 475-483

  Poirier, Raphael ^a   Wolfer, David P ^a   Welzl, Hans ^a   Tracy, Jay ^a   Galsworthy, Michael J ^a   Nitsch, Roger M ^a   Mohajeri, M Hasan ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

A clearance; Alzheimer; Behavior; CD10; Cognition; Therapy

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE METALLOENDOPEPTIDASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPATIAL MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; AVOIDANCE LEARNING; BRAIN; COGNITION DISORDERS; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEPRILYSIN; NEURONS; SINGLE-BLIND METHOD; UP-REGULATION;

EID: 33750841488     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.08.003     Document Type: Article

References (64)

1. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., and Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110 (2002) 55-67
2. Berger-Sweeney J., McPhie D.L., Arters J.A., Greenan J., Oster-Granite M.L., and Neve R.L. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein. Brain Res. Mol. Brain Res. 66 (1999) 150-162
3. Buttini M., Yu G.Q., Shockley K., Huang Y., Jones B., Masliah E., Mallory M., Yeo T., and Mucke F.M. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J. Neurosci. 22 (2002) 10539-10548
4. Cao X., and Sudhof T.C. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
5. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
6. Cui Z., Lindl K.A., Mei B., Zhang S., and Tsien J.Z. Requirement of NMDA receptor reactivation for consolidation and storage of nondeclarative taste memory revealed by inducible NR1 knockout. Eur. J. Neurosci. 22 (2005) 755-763
7. Cullen W.K., Suh H., Anwyl R., and Rowan M.J. Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments. NeuroReport 8 (1997) 3213-3217
8. Dawson G.R., Seabrook G.R., Zheng H., Smith D.W., Graham S., O'Dowd G., Bowery B.J., Boyce S., Trumbauer M.E., Chen H.Y., Van der Ploeg L.H., and Sirinathsinghji D.J. Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90 (1999) 1-13
9. De Felice F.G., Vieira M.N., Saraiva L.M., Figueroa-Villar J.D., Garcia-Abreu J., Liu R., Chang L., Klein W.L., and Ferreira S.T. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J. 18 (2004) 1366-1372
10. Dickson D.W., Crystal H.A., Bevona C., Honer W., Vincent I., and Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol. Aging 16 (1995) 285-298
11. Dodart J.C., Bales K.R., Gannon K.S., Greene S.J., DeMattos R.B., Mathis C., DeLong C.A., Wu S., Wu X., Holtzman D.M., and Paul S.M. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 5 (2002) 452-457
12. Dodel R.C., Hampel H., and Du Y. Immunotherapy for Alzheimer's disease. Lancet Neurol. 2 (2003) 215-220
13. Ferreira G., Gutierrez R., De La Cruz V., and Bermudez-Rattoni F. Differential involvement of cortical muscarinic and NMDA receptors in short- and long-term taste aversion memory. Eur. J. Neurosci. 16 (2002) 1139-1145
14. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1996), Academic Press, San Diego, CA
15. Fukuchi K., Sopher B., Furlong C.E., Smith A.C., Dang N., and Martin G.M. Selective neurotoxicity of COOH-terminal fragments of the beta-amyloid precursor protein. Neurosci. Lett. 154 (1993) 145-148
16. Furukawa K., and Mattson M.P. Secreted amyloid precursor protein alpha selectively suppresses N-methyl-d-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83 (1998) 429-438
17. Gelinas D.S., DaSilva K., Fenili D., St George-Hyslop P., and McLaurin J. Immunotherapy for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 101 Suppl. 2 (2004) 14657-14662
18. Giannakopoulos P., Hof P.R., Michel J.P., Guimon J., and Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Brain Res. Rev. 25 (1997) 217-245
19. Glatzel M., Mohajeri M.H., Poirier R., Nitsch R.M., Schwarz P., Lu B., and Aguzzi A. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis. J. Gen. Virol. 86 (2005) 1861-1867
20. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
21. Howell S., Nalbantoglu J., and Crine P. Neutral endopeptidase can hydrolyze beta-amyloid(1-40) but shows no effect on beta-amyloid precursor protein metabolism. Peptides 16 (1995) 647-652
22. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
23. Imai Y., Ibata I., Ito D., Ohsawa K., and Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 224 (1996) 855-862
24. Ishida A., Furukawa K., Keller J.N., and Mattson M.P. Secreted form of beta-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. NeuroReport 8 (1997) 2133-2137
25. Iwata N., Higuchi M., and Saido T.C. Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol. Ther. 108 (2005) 129-148
26. Iwata N., Mizukami H., Shirotani K., Takaki Y., Muramatsu S., Lu B., Gerard N.P., Gerard C., Ozawa K., and Saido T.C. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J. Neurosci. 24 (2004) 991-998
27. Janus C., Welzl H., Hanna A., Lovasic L., Lane N., St George-Hyslop P., and Westaway D. Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol. Aging 25 (2004) 1213-1219
28. Kawasumi M., Matsuda S., Matsuoka M., and Nishimoto I. Cytoplasmic tail adaptors of Alzheimer's amyloid-beta protein precursor. Mol. Neurobiol. 30 (2004) 185-200
29. Kim H.S., Kim E.M., Lee J.P., Park C.H., Kim S., Seo J.H., Chang K.A., Yu E., Jeong S.J., Chong Y.H., and Suh Y.H. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J. 17 (2003) 1951-1953
30. Kinoshita A., Whelan C.M., Berezovska O., and Hyman B.T. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J. Biol. Chem. 277 (2002) 28530-28536
31. Kinoshita A., Shah T., Tangredi M.M., Strickland D.K., and Hyman B.T. The intracellular domain of the low density lipoprotein receptor-related protein modulates transactivation mediated by amyloid precursor protein and Fe65. J. Biol. Chem. 278 (2003) 41182-41188
32. Klyubin I., Walsh D.M., Lemere C.A., Cullen W.K., Shankar G.M., Betts V., Spooner E.T., Jiang L., Anwyl R., Selkoe D.J., and Rowan M.J. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 11 (2005) 556-561
33. Lee K.W., Lee S.H., Kim H., Song J.S., Yang S.D., Paik S.G., and Han P.L. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J. Neurosci. Res. 76 (2004) 572-580
34. Leissring M.A., Farris W., Chang A.Y., Walsh D.M., Wu X., Sun X., Frosch M.P., and Selkoe D.J. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40 (2003) 1087-1093
35. Lu B., Gerard N.P., Kolakowski Jr. L.F., Bozza M., Zurakowski D., Finco O., Carroll M.C., and Gerard C. Neutral endopeptidase modulation of septic shock. J. Exp. Med. 181 (1995) 2271-2275
36. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., and Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23 (2003) 1992-1996
37. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., and Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10 (1993) 243-254
38. McGaugh J.L., McIntyre C.K., and Power A.E. Amygdala modulation of memory consolidation: interaction with other brain systems. Neurobiol. Learn. Mem. 78 (2002) 539-552
39. Meziane H., Dodart J.C., Mathis C., Little S., Clemens J., Paul S.M., and Ungerer A. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12683-12688
40. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Checler C.V., Godaux F., Cordell E., and Van Leuven B. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274 (1999) 6483-6492
41. Mohajeri M.H., Wollmer M.A., and Nitsch R.M. Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J. Biol. Chem. 277 (2002) 35460-35465
42. Mohajeri M.H., Kuehnle K., Li H., Poirier R., Tracy J., and Nitsch R.M. Anti-amyloid activity of neprilysin in plaque-bearing mouse models of Alzheimer's disease. FEBS Lett. 562 (2004) 16-21
43. Morris R. Spatial localization does not depend on the presence of local cues. Learn. Motiv. 12 (1981) 239-260
44. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., and McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20 (2000) 4050-4058
45. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1 (1992) 345-347
46. Murrell J., Farlow M., Ghetti B., and Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254 (1991) 97-99
47. Nalbantoglu J., Tirado-Santiago G., Lahsaini A., Poirier J., Goncalves O., Verge G., Momoli F., Welner S.A., Massicotte G., Julien J.P., and Shapiro M.L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387 (1997) 500-505
48. Ohsawa I., Takamura C., and Kohsaka S. The amino-terminal region of amyloid precursor protein is responsible for neurite outgrowth in rat neocortical explant culture. Biochem. Biophys. Res. Commun. 236 (1997) 59-65
49. Ohsawa K., Imai Y., Kanazawa H., Sasaki Y., and Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 113 Pt. 17 (2000) 3073-3084
50. Oster-Granite M.L., McPhie D.L., Greenan J., and Neve R.L. Age-dependent neuronal and synaptic degeneration in mice transgenic for the C terminus of the amyloid precursor protein. J. Neurosci. 16 (1996) 6732-6741
51. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q., Raber J., Masliah E., and Mucke L. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9572-9577
52. Roncarati R., Sestan N., Scheinfeld M.H., Berechid B.E., Lopez P.A., Meucci O., McGlade J.C., Rakic P., and D'Adamio L. The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 7102-7107
53. Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat. Rev., Neurosci. 3 (2002) 824-828
54. Seabrook G.R., Smith D.W., Bowery B.J., Easter A., Reynolds T., Fitzjohn S.M., Morton R.A., Zheng H., Dawson G.R., Sirinathsinghji D.J., Davies C.H., Collingridge G.L., and Hill R.G. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38 (1999) 349-359
55. Selkoe D.J., and Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 545-584
56. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., and Mattson M.P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63 (1994) 781-784
57. Sopher B.L., Fukuchi K., Smith A.C., Leppig K.A., Furlong C.E., and Martin G.M. Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res. Mol. Brain Res. 26 (1994) 207-217
58. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
59. Turner P.R., O'Connor K., Tate W.P., and Abraham W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 70 (2003) 1-32
60. Welzl H., D'Adamo P., and Lipp H.P. Conditioned taste aversion as a learning and memory paradigm. Behav. Brain Res. 125 (2001) 205-213
61. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., and Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22 (2002) 1858-1867
62. Wolfer D.P., Madani R., Valenti P., and Lipp H.P. Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol. Behav. 73 (2001) 745-753
63. Wong P.C., Cai H., Borchelt D.R., and Price D.L. Genetically engineered mouse models of neurodegenerative diseases. Nat. Neurosci. 5 (2002) 633-639
64. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., and Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245 (1989) 417-420